Beware the cat: Bartonella henselae infections and biologic therapies

Joint Bone Spine. 2018 May;85(3):381-382. doi: 10.1016/j.jbspin.2017.05.015. Epub 2017 May 19.

Authors

Camelia Rossi¹, Rakan Nasreddine², France Laurent², Nathalie Demeulenaere³, Marc Léon³

Affiliations

¹ Division of Infectious Disease, CHU Ambroise-Paré, boulevard Kennedy 2, 7000 Mons, Belgium. Electronic address: camelia.rossi@hap.be.
² Division of Infectious Disease, CHU Ambroise-Paré, boulevard Kennedy 2, 7000 Mons, Belgium.
³ Division of Rheumatology, CHU Ambroise-Paré, boulevard Kennedy 2, 7000 Mons, Belgium.

PMID: 28532821
DOI: 10.1016/j.jbspin.2017.05.015

No abstract available

Keywords: Bartonella henselae; Biologic therapies; Infectious complications; Rheumatic diseases.

Publication types

Letter

MeSH terms

Abatacept / therapeutic use
Aged
Animals
Antibodies, Monoclonal / therapeutic use
Arthritis, Rheumatoid / diagnosis
Arthritis, Rheumatoid / drug therapy*
Bartonella henselae / isolation & purification*
Biological Therapy / adverse effects*
Biological Therapy / methods
Biopsy, Needle
Cat-Scratch Disease / diagnosis
Cat-Scratch Disease / pathology*
Cats
Female
Follow-Up Studies
Humans
Immunohistochemistry
Risk Assessment
Sampling Studies
Spondylitis, Ankylosing / drug therapy*
Young Adult

Substances

Antibodies, Monoclonal
Abatacept
golimumab